Why is Windlas Biotech falling/rising?

As of 19-Sep, Windlas Biotech Ltd's stock is currently priced at 962.50, reflecting a slight increase of 1.0 (0.1%). The stock has shown a trend reversal, gaining after three consecutive days of decline. It is performing in line with its sector today, and while it is trading above the 100-day moving average, it remains below the 5-day, 20-day, 50-day, and 200-day moving averages. The stock has experienced a decline of 3.69% over the past week and 7.89% over the past month, although it has generated a positive return of 11.94% over the past year. The company has reported strong financial results, with net sales and profits at their highest levels recently, and it maintains a low debt-to-equity ratio, which supports its valuation despite trading at a premium compared to peers.
In the broader market context, Windlas Biotech's recent performance contrasts with the Sensex, which has gained 0.88% over the past week and 1.20% over the past month. The stock's year-to-date performance shows a decline of 6.87%, while the Sensex has increased by 5.74% during the same period. Despite these challenges, the stock has consistently outperformed the BSE500 over the last three years, indicating strong historical returns. The rising investor participation, as evidenced by an increase in delivery volume, suggests a growing interest in the stock, which may help stabilize its price in the face of broader market fluctuations.